OxyContin Maker Explored Expansion Into “Attractive” Anti-Addiction Market
By David Armstrong Secret portions of a lawsuit allege that Purdue Pharma, controlled by the Sackler family, considered capitalizing on the addiction treatment boom — while going to extreme lengths to boost sales of its controversial opioid. This story was co-published with STAT. Not content…